These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12839429)

  • 1. Switching to bupropion in fluoxetine-resistant major depressive disorder.
    Fava M; Papakostas GI; Petersen T; Mahal Y; Quitkin F; Stewart J; McGrath P
    Ann Clin Psychiatry; 2003 Mar; 15(1):17-22. PubMed ID: 12839429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
    DeBattista C; Solvason HB; Poirier J; Kendrick E; Schatzberg AF
    J Clin Psychopharmacol; 2003 Feb; 23(1):27-30. PubMed ID: 12544372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
    Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
    J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion: a review of its use in the management of major depressive disorder.
    Dhillon S; Yang LP; Curran MP
    Drugs; 2008; 68(5):653-89. PubMed ID: 18370448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion as an augmenting agent in patients of depression with partial response.
    Gulrez G; Badyal DK; Deswal RS; Sharma A
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):227-30. PubMed ID: 21895979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
    Thase ME; Haight BR; Richard N; Rockett CB; Mitton M; Modell JG; VanMeter S; Harriett AE; Wang Y
    J Clin Psychiatry; 2005 Aug; 66(8):974-81. PubMed ID: 16086611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
    Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
    J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
    Rush AJ; South C; Jha MK; Jain SB; Trivedi MH
    J Clin Psychiatry; 2020 Aug; 81(5):. PubMed ID: 32780949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.
    Cooper JA; Tucker VL; Papakostas GI
    J Psychopharmacol; 2014 Feb; 28(2):118-24. PubMed ID: 24352716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    Papakostas GI; Trivedi MH; Alpert JE; Seifert CA; Krishen A; Goodale EP; Tucker VL
    J Psychiatr Res; 2008 Jan; 42(2):134-40. PubMed ID: 17631898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ; Trivedi MH; Wisniewski SR; Stewart JW; Nierenberg AA; Thase ME; Ritz L; Biggs MM; Warden D; Luther JF; Shores-Wilson K; Niederehe G; Fava M;
    N Engl J Med; 2006 Mar; 354(12):1231-42. PubMed ID: 16554525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.
    Clayton AH; McGarvey EL; Abouesh AI; Pinkerton RC
    J Clin Psychiatry; 2001 Mar; 62(3):185-90. PubMed ID: 11305705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
    Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
    Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders.
    Doraiswamy PM; Khan ZM; Donahue RM; Richard NE
    Am J Geriatr Psychiatry; 2001; 9(4):423-8. PubMed ID: 11739069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Kinrys G; Burns AM; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Clin Psychiatry; 2005 Oct; 66(10):1326-30. PubMed ID: 16259548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.
    Chengappa KN; Kambhampati RK; Perkins K; Nigam R; Anderson T; Brar JS; Vemulapalli HK; Atzert R; Key P; Kang JS; Levine J
    J Clin Psychiatry; 2001 Jul; 62(7):503-8. PubMed ID: 11488359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.